|
Morbosità e Mortalità dopo la vaccinazione polio in Assam
India: post-vaccination 20001220.2234
- Poliomyelitis, suspected
Mon 12 Nov 2001 23:22:27 –0600 - Henry V. Huang - BBC
News Online, Mon 12 Nov 2001 [edited]
http://news.bbc.co.uk/hi/english/health/newsid_1651000/1651863.stm
INDIA
- vedi anche
QUI .....
e
QUI - vedi:
i vaccini diffondono le malattie
In
INDIA DOPO le grandi campagne di vaccinazione per la
poliomielite,
dell'OMS,
Bill
Gates e Rockefeller, e', cosi dicono, le
autorita' ufficiali, colluse con
Big
Pharma..., ricomparsa la
polio....pero'
dicono che e' la conseguenza, la colpa di un
virus
detto "selvaggio" (non
addomesticato....ha...ha...ha...) pur di non accettare
la verita' = sono le
vaccinazioni di massa che propagano la
Poliomielite
!
Sono i
vaccini per la polio che hanno utilizzato nelle
campagne di
vaccinazione in INDIA e
paesi del terzo mondo (OMS
+
Bil Gates + Rockefeller & C....) che diffondono e
propagano la
polio e danno la colpa al "virus selvaggio"
!....questo ....perche'
Bill Gates e' stato messo sotto processo in India per
strage -
paralisi
e morti,
per la
campagna di vaccinazione per la
polio,
che ha
finanziato direttamente con la sua fondazione ! ....che
BUGIARDI, CRIMINALI....
Tenete presente che quella tossina virale per la polio
e' endemica negli intestini delle popolazioni del terzo
mondo e sui soggetti malnutriti od
immunodepressi dai vaccini che hanno subito in
precedenza, queste tossine virali,
producono molti
e qualsiasi possibili danni....dalle
disfunzioni dello sviluppo,
autismo,
allergie alle
paralisi e morte !
Nei paesi
del terzo mondo utilizzano un vaccino per sterilizzare
le femmine ! - vedi:
Contenuto dei Vaccini
Morbidity and Mortality
after Polio vaccination in
Assam
CALCUTTA: At least 10 children have died in India's
northeastern state of Assam of side effects after
being administered a vaccine during an polio
immunisation campaign run by the state government.
More than 500 children have been admitted to
government and private hospitals after falling sick.
Angry groups of parents have surrounded offices of the
local administration in protest in Assam's southern
city of Silchar.
On Sunday, thousands of children were administered a
Polio vaccine throughout Assam and the rest of the
country. But within a day of the massive polio
immunisation campaign, reports have come in of
large-scale side effects in and around the city of
Silchar in southern Assam. Officials say 9 children
have died in one village -- Labok -- while one died in
Malugram locality of Silchar.
Non-governmental organisations in Silchar who assist
the government in this campaign say outdated vaccines
were possibly supplied in some areas. But officials
were not willing to speculate on the causes of the
large-scale side effects. [Byline: Subir Bhaumik]
Henry V. Huang Dept. of Molecular Microbiology
Washington U. School of Medicine - Box 8230, 660 S.
Euclid Avenue - St. Louis, MO 63110-1093 USA -
huang@borcim.wustl.edu
L’Immunità di gregge, è
la supposta carta
vincente per la difesa
della vaccinazione in
TV, Internet, riviste
mediche e giornali, sul
motivo per cui
dovremmo essere
vaccinati più e più
volte per tutta la vita,
con un numero sempre
crescente di vaccini e
cio' per ogni malattia.
Lo
sbandierato a 360° "supposto
successo delle vaccinazioni" è basato
fondamentalmente su "teorie" che si danno per
scontate, senza controllarle. Quando si entra nei
particolari si evince e si dimostra invece che il
tasso di incidenza e di morte di molte malattie
infettive, è diminuito radicalmente nel e dal
momento in cui si registrava un miglioramento delle
condizioni, igienico-sanitarie, abitative,
alimentari e delle procedure di isolamento,
Pero' siccome nello stesso periodo sono stati
introdotti i vaccini, la
medicina ufficiale ha dato per scontato che la
sola vaccinazione sia stata interamente responsabile
della scomparsa di queste "malattie" e per far
quadrare questa teoria fasulla, ha cambiato nome
alle malattie.....QUI
in queste pagine ve ne
daremo la dimostrazione !
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Uno studio scientifico mostra che il vaccino
quadrivalente per il papilloma virus può causare
vasculopatia autoimmuni
fatali (ovvero
mortali).
Lo studio
realizzato dai due medici canadesi Lucija
Tomljenovic e Cristopher A. Shaw si intitola "Morte dopo
il vaccino contro il papilloma virus, c'è una relazione
causale o è una coincidenza ? " e si può leggere (in
inglese) al seguente link
http://sanevax.org/wp-content/uploads/2012/10/Tomljenovic-Shaw-Gardasil-Causal-Coincidental-2167-7689-S12-001.pdf.
Le conclusioni dell'articolo non sono per niente
ambigue: il vaccino in questione può innescare una
reazione autoimmune che può essere talora mortale. Le
conclusioni sono motivate dal fatto che molte delle
reazioni avverse a tale vaccino finora registrate
corrispondono a sintomi di
vasculopatia cerebrale.
Studi come questo ovviamente mettono in un angolo tutti
i
ministeri della
sanità che negano continuamente ogni correlazione
tra le morti ed i vaccini.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Vaccino Sabin (quello per la
Polio)
miete
vittime
in
Repubblica Dominicana e nelle Filippine
Il virus contenuto nel vaccino della polio, liberatosi
anche nell'ambiente a causa della
vaccinazione di massa con
il vaccino Sabin, ha fatto solo nell’anno 2000, 19
vittime nella Repubblica Dominicana, che hanno
riportato la polio paralitica a causa dell'infezione
procurata dal vaccino “sabin”.
Fra marzo e luglio 2001, altri 3 casi si sono
verificati nelle Filippine.
vedi "Mortality and Morbidity Weekly Report", 12
ott. 2001/50(40); 874-5.
Le 3 persone
erano state vaccinate in precedenza
per la la polio.
E’ emerso quindi chiaramente che la
vaccinazione non copre dal virus del vaccino Sabin.
Vaccinando con il Sabin (il vaccino orale con
virus attenuato in
formalina, prodotto notoriamente
cancerogeno) in paesi dove non esiste un sistema
fognario che divida le acque di scarico da quelle
domestiche il virus vaccinico della polio viene reimmesso nell'ambiente attraverso le feci.
Anche stavolta il virus del vaccino sabin è rimasto
latente anche nell'ambiente per un periodo sufficientemente
lungo di tempo per acquisire modificazioni genetiche e
riacquistare neurovirulenza,
producendo nuovi casi di malattia in soggetti
già vaccinati, per i noti meccanismi di
slatentizzazione,
Ugualmente
è accaduto anche in
Africa per
l’Aids……..scatenato dalle
campagne vaccinali del
decennio degli anni 70’
Siamo infatti di fronte ad un ulteriore nuovo e mutato
virus (il sabin), alla cui origine vi è esclusivamente
la
colpa umana della cosiddetta “scienza medica”,
manipolatrice di virus
altamente pericolosi; di fatto
trattasi di guerra batteriologica…...
La celebre rivista medica Lancet già un anno ha
invitato ad abbandonare il Sabin e vaccinare solo con
Salk per non peggiorare la situazione.
Invece il governo filippino ha deciso di iniziare una
nuova campagna di vaccinazione di massa con il Sabin…….le scorte di
vaccino delle
multinazionali……hanno “convinto” qualche ministro…..ad
ignorare i fatti ed a smaltire quei
vaccini
pericolosi
che sono stati inoculati, lo ricordiamo. anche su
oltre 450 milioni di europei; il vaccino sabin è stato
contaminato da un altro virus scimmiesco lo
SV 40
concausa del cancro chiamato “mesiotelioma” dagli anni
50’ fino agli anni 80’ !!!
vedi:
Perche' vaccinare ?
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
SMALLPOX VACCINE, WHO STATEMENT
Date: Tue 22 Oct 2001 - From: Jaime R. Torres,
ProMED-ESP - Source: BBC Mundo [edited];
[translated by MJ)
http://news.bbc.co.uk/hi/spanish/science/newsid_1613000/1613692.stm
WHO Statement on Smallpox Vaccination Policy
The World Health Organization, WHO, stated that it is
reconsidering using the vaccine against smallpox, in
light of the possible use of the virus as a biological
weapon. Smallpox is considered to have been officially
eradicated in 1980. For years, there have been no
cases reported. Nonetheless, because of the potential
for the use of the virus in terrorist actions, WHO has
decided to include it in the list of 11 diseases that
might be used by extremist groups.
Ian Simpson, spokesman for the organization, stated
that WHO's recommendation to governments is that they
verify their level of preparedness to handle diseases,
including smallpox. The resurgence of fear related to
smallpox was prompted by the cases of anthrax in the
US.
However, unlike anthrax, smallpox is a highly
contagious disease among humans. Nonetheless, the
vaccine may be effective in preventing or reducing the
severity of the clinical disease, up until 4 days
after the person has been infected. Contrary to
popular belief, the immunity conferred by the vaccine
is not for life and, in many cases, it is necessary to
administer booster doses every 5 to 10 years in order
to maintain protective levels of neutralizing
antibodies.
WHO calculates that there are close to 90 million
doses of the vaccine stored by governments for use in
civilian populations. However, manufacture of the
vaccine involves a complex procedure and some
specialists affirm that it is probable that the WHO
will maintain its recommendations against massive
vaccination.
For the time being, although there are no indications
of a possible terrorist act with the smallpox virus,
the United States has begun to multiply its vaccine
reserves, according to a multi-tiered plan that even
contemplates immunizing the entire population of the
country.
Some scientists calculate that a massive vaccination
campaign could take months, even years, and that by
the time of its conclusion, the threat may well have
vanished.
ProMED-mail -
promed@promedmail.org
[Smallpox vaccine -- which is made from vaccinia & not
smallpox virus -- saved many more lives than those who
died from adverse reactions. The major problem with
restarting mass vaccination in the absence of disease
is that adverse reactions will kill some people --
perhaps many in this age of AIDS & lowered immunity.
Remember the swine flu vaccine problems ? - Mod.JW]
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
SMALLPOX VACCINE, WHO STATEMENT (02)
Date: Fri 26 Oct 2001 - From: Daniel B. Epstein (WDC)
-
epsteind@paho.org
Source: Statement WHO/16, Fri 26 Oct 2001 [edited]
http://www.who.int/inf-pr-2001/en/state2001-16.html
Statement to the Press by the Director-general of the
WHO, Dr Gro Harlem Brundtland: World Health
Organization Announces Updated Guidance on Smallpox
Vaccination
GENEVA: Following the review of guidance on smallpox
vaccination I announced last week, WHO has consulted
with our advisory committee and has updated the
official guidance. The conclusion of the review states
that:
"Existing vaccines have proven efficacy but also have
a high incidence of adverse side-effects. The risk of
adverse events is sufficiently high that mass
vaccination is not warranted if there is no or little
real risk of exposure. Individual countries that have
reason to believe that their people face an increased
risk of smallpox because of deliberate use of the
virus are considering options for increasing their
access to vaccines.
The vaccines would be given to people who are at risk
of exposure to smallpox, including health and civil
workers, and would be used in a search and containment
exercise should an outbreak occur.
In summary, the guidance is that vaccination of entire
populations is not recommended. The reason for not
recommending such mass vaccination is that there is a
risk of severe reactions to the vaccine, *including
death*, and the fact that vaccination can prevent
smallpox even after exposure to the virus.
Up to now the guidance has also stated that only those
with suspected exposure to smallpox or a related virus
should be vaccinated. That has not changed. What has
changed is the increasing attention being given to the
extent and quality of existing vaccine stocks, and to
the possible need both to stimulate vaccine production
and increase stocks of vaccine for use in the event of
an outbreak. WHO confirms that the best method of
stopping a smallpox outbreak, should it occur, remains
the same -- search and containment. That means
identifying persons with smallpox, identifying those
people who have been in contact with them, and
vaccinating them.
*People who have been vaccinated in the past are
unlikely to develop the most serious effects of
smallpox.*
This advice and background information on smallpox is
now being made available to governments through the
WHO web-site:
http://www.who.int>www.who.int
Along with this advice we are providing Frequently
asked Questions and Answers about smallpox and a
smallpox Fact Sheet with an electronic slide set of
training materials on smallpox.
Other information that will be provided to Health
Ministers on request includes a list of vaccine
manufacturers that have the potential to produce
smallpox vaccine and the names of laboratories that
can diagnose smallpox. WHO has also re-established a
team of technical experts in smallpox who are
available to assist countries in the investigation and
response to outbreaks.
Finally, I want to emphasize that should an outbreak
of smallpox be detected in any country, this should be
considered an international emergency. WHO will help
countries to pool available resources so as to contain
the disease as rapidly and effectively as possible."
Daniel Epstein - Information Officer
Pan American Health Organization/World Health
Organization 525 23rd St., NW - Washington D.C. 20037
- (by "BBC News Online", Mon 22, 26 Oct e 12 Nov 2001)
Vaccino Sabin (quello per la
Polio) miete vittime In
Repubblica Dominicana e nelle Filippine
Il virus contenuto nel vaccino della polio, liberatosi
nell'ambiente a causa della vaccinazione di massa con
il vaccino Sabin, ha fatto solo nell’anno 2000, 19
vittime nella Repubblica Dominicana, che hanno
riportato la polio paralitica a causa dell'infezione
procurata dal virus “sabin”.
Fra marzo e luglio 2001, altri 3 casi si sono
verificati nelle Filippine.
(vedi "Mortality and Morbidity Weekly Report", 12
ottobre 2001/50(40); 874-5).
Le 3 persone
erano state vaccinate in precedenza contro la polio.
E’ emerso quindi chiaramente che la
vaccinazione non copre dal virus del vaccino Sabin.
Vaccinando con il Sabin (il vaccino orale con virus
vivo attenuato in formalina, prodotto notoriamente
cancerogeno) in paesi dove non esiste un sistema
fognario che divida le acque di scarico da quelle
domestiche il virus vaccinico della polio viene
reimmesso nell'ambiente attraverso le feci.
Anche stavolta il virus del vaccino sabin è rimasto
latente nell'ambiente per un periodo sufficientemente
lungo di tempo per acquisire modificazioni genetiche e
riacquistare neurovirulenza,
producendo nuovi casi di malattia in soggetti
già vaccinati,
Ugualmente
è accaduto anche in Africa per
l’Aids……..scatenato dalle campagne vaccinali del
decennio degli anni 70’
Siamo infatti di fronte ad un ulteriore nuovo e mutato
virus (il sabin), alla cui origine vi è esclusivamente
la colpa umana della cosiddetta “scienza medica”,
manipolatrice di virus altamente pericolosi; di fatto
trattasi di guerra batteriologica…...
La celebre rivista medica Lancet già un anno ha
invitato ad abbandonare il Sabin e vaccinare solo con
Salk per non peggiorare la situazione.
Invece il governo filippino ha deciso di iniziare una
nuova campagna di vaccinazione di massa con il
Sabin…….le scorte di vaccino delle
multinazionali……hanno “convinto” qualche ministro…..ad
ignorare i fatti ed a smaltire quei vaccini pericolosi
che sono stati inoculati, lo ricordiamo. anche su
oltre 450 milioni di europei; il vaccino sabin è stato
contaminato da un altro virus scimmiesco lo
SV 40
concausa del cancro chiamato “mesiotelioma” dagli anni
50’ fino agli anni 80’ !!!
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Dall'International Society for Infectious Diseases.
POLIOMYELITIS,
VACCINE-DERIVED - PHILIPPINES: 2001
[see also:
Poliomyelitis - Dominican Republic & Haiti
20011005.2415
Polio, circulation of vaccine-derived virus
20010129.0205
2000
-------
Poliomyelitis - Dominican Rep.: control measures
20001218.2212
Poliomyelitis - Dominican Republic & Haiti: ALERT
20001202.2098
Poliomyelitis - Dominican Republic & Haiti: background
20001203.2102
Poliomyelitis - Dominican Republic & Haiti: comment
20001204.2110
Poliomyelitis - Dominican Republic & Haiti: update
20001208.2149
Poliomyelitis - Dominican Republic: visitor advice
20001215.2195]
Date: 12 Oct 2001
From: ProMED-mail <<mailto:promed@promedmail.org>promed@promedmail.org>
Source: MMWR 50(40);874-5 [edited]
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5040a3.htm
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5040a3.htm
Public Health Dispatch: Acute Flaccid Paralysis
Associated with Circulating Vaccine-Derived Poliovirus
--- Philippines, 2001
Three cases of acute flaccid paralysis (AFP)
associated with circulating vaccine-derived poliovirus
(cVDPV) isolates were reported in the Philippines
during March 15--July 26, 2001.
The first
case-patient, a child aged 8 years from northern
Mindanao island (500 miles south of Manila) who had
received 3 doses of oral polio vaccine (OPV), had
onset of paralysis on
March 15. A second child, aged 3 years from Laguna
province on Luzon island (60 miles south of Manila)
who had received 3 OPV doses, presented with signs of
meningitis but no paralysis on July 23. A third child,
aged 14 months from Cavite province (25 miles from
Manila and 45 miles north of Laguna province) who had
received 2 OPV doses, had onset of paralysis on
July 26. No patients had traveled outside of their
province of residence since birth. Characterization of
isolates from the 3 patients revealed type 1
polioviruses derived from Sabin vaccine strain type 1,
with a 3% genetic sequence difference between Sabin 1
vaccine and vaccine-derived poliovirus (VDPV) isolates.
The 3 polioviruses are not identical but are closely
related (99% sequence homology); they also appear to
share an identical recombination site with a nonpolio
enterovirus in the noncapsid
region of the genome.
Following cVDPV outbreaks in the Dominican Republic
and Haiti (Hispaniola) during 2000--2001 (1), the
global polio laboratory network implemented additional
testing requirements for all polioviruses under
investigation, prospectively and retrospectively. Both
an antigenic-based (ELISA) and a molecular-based test
(probe hybridization) are used to determine whether a
poliovirus is wild or derived from vaccine (i.e.,
intratypic differentiation [ITD]). Divergent ITD
results (one test showing vaccine-derived and the
other wild-type virus) for any poliovirus isolate now
require genomic sequencing of the suspect isolates.
Retrospective
testing of 2000 vaccine-related isolates from AFP
cases globally has revealed no additional cVDPVs,
although testing results of other isolates in the
laboratory network are pending. The cVDPVs from the
Philippines were detected after the implementation of
new testing requirements for prospective virus
investigations.
In response to these cases, the Department of Health
in the Philippines
1) enhanced surveillance by active record review for
AFP cases in hospitals and other health-care
facilities in the affected and neighboring provinces,
2) established surveillance to conduct virologic
investigations of aseptic meningitis at major
health-care facilities, 3) collected stool samples
from healthy contacts of case-patients,
4) conducted field investigations of clustered AFP
cases to determine the extent of cVDPV circulation,
and
5) assessed polio vaccination coverage in these
communities. The investigations have found no
unreported cases, although some AFP cases remain under
investigation. To interrupt cVDPV circulation, a
large-scale mass vaccination campaign with OPV is
planned.
Low routine vaccination coverage is one of the most
important causes of VDPV. Because the location of the
originating events is unknown, the contribution of
other factors is difficult to assess; however, a
combination of 2 concurrent events within the virus is
necessary for cVDPV emergence: reversion of
attenuating mutations to increase neurovirulence, and
a presumed increase in transmission characteristics
that might be related to recombination with a nonpolio
enterovirus.
The molecular basis for the second property is not
understood.
Wild poliovirus was last reported in the Philippines
in 1993 (2), and national vaccination rounds were last
conducted in the Philippines in 1997 followed by
subnational immunization days in 1998 and 1999.
Among the areas covered were Cebu, Davao, Manila, and
parts of Mindanao; however, coverage did not extend to
the 3 provinces now reporting cVDPV cases. Routine
coverage with 3 OPV doses has been approximately 80%
nationwide since
the early 1990s; however, coverage gaps are likely,
particularly in slum areas.
Travelers to the Philippines should ensure that they
are vaccinated appropriately against polio according
to national recommendations (3).
Reported by: National Epidemiology Center, National
Center for Disease Prevention and Control, Research
Institute of Tropical Medicine, Dept of Health; World
Health Organization, Manila, Philippines. Regional
Reference Laboratory, Victorian Infectious Diseases
Reference Laboratory, Fairfield, Victoria, Australia.
Global Specialized Laboratory, National Institute of
Infectious Diseases, Tokyo, Japan. Vaccines and
Biologicals Dept, World Health Organization, Geneva,
Switzerland. Respiratory and Enteric Viruses Br, Div
of Viral and Rickettsial Diseases, National Center for
Infectious Diseases; Vaccine Preventable Disease
Eradication Div, National Immunization Program, CDC.
References
CDC update: outbreak of poliomyelitis---Dominican
Republic and Haiti, 2000--2001. MMWR 2001;50:855--6.
CDC. Progress toward poliomyelitis
eradication---Western Pacific Region, January 1,
1996--September 27, 1997. MMWR 1997;46:1113--7.
CDC. Poliomyelitis prevention in the United States:
updated recommendations of the Advisory Committee on
Immunization Practices. MMWR 2000;49(no. RR-5).
ProMED-mail
<<mailto:promed@promedmail.org>promed@promedmail.org>
[This is now the third documented episode of
poliomyelitis-like illness (acute flaccid paralysis -
AFP) due to circulating vaccine derived poliovirus (cVDPV)
with reversion to neurovirulence. The 2 prior episodes
were on the island of Hispaniola (Dominican Republic
and Haiti) and in Egypt (see referenced ProMED-mail
postings above). In addition, there were reports of
circulating vaccine derived poliovirus in Israel
identified in sewage sampling but not associated with
clinical illness (also reported in above ProMED-mail
postings).
One wonders if this is a case of "seek and ye shall
find" or if this is an emerging problem associated
with the disease. The former seems to be preliminarily
ruled out by the failure of a retrospective study of
over 2000 AFP associated poliovirus isolates to
identify additional VDPV, albeit if it is a low level
occurrence, we may miss it by virtue of the rarity of
the event. If the latter is the case, one wonders why
now, after approximately 50 years of use are we seeing
this phenomenon. If one rejects the reference of "approximately
50 years of use" and chooses to further refine the
date to when increased vaccination activities
associated with the polio eradication effort began,
then the time frame for widespread use is
approximately 16 years, when polio eradication
activities in the Americas region began.
Of note is that this has occurred in 3 different
regions of the world -- the Middle East (Egypt and
Israel), the Americas (Hispaniola) and now in the
Western Pacific (Philippines). In 2 areas (Hispaniola
and the Philippines) circulation of the wild
poliovirus had been interrupted (the last reported
case of wild poliovirus associated disease in the
Americas was in 1991 and in the Philippines in 1993).
In the absence of total interruption of wild
poliovirus circulation world-wide there is still a
need to keep up intensified vaccination efforts as the
risk of disease is still present, especially in
today's environment with extensive travel world-wide.
The occurrence of cVDPV in association with clinical
disease is very disturbing as it adds another factor
into the risk benefit equation of vaccination
recommendations. As mentioned in an earlier comment, a
cost-efficacy analysis of switching to the inactivated
vaccine (inactivated polio vaccine - IPV) in countries
that have interrupted wild virus circulation
probably negates the economic viability of such a
recommendation. In addition, and not an
insignificant addition is that a switch to the IPV
would remove the advantage of flooding the
environment with the vaccine virus (the attenuated
very low-neurovirulence virus) to further interrupt
transmission of wild poliovirus if introduced as
well as to "vaccinate" individuals who may not have
directly taken the vaccine themselves.
Tratto da: VacciNetwork del 22.11.2001
Commento NdR:
questi
studi dimostrano e confermano cio'
che insegniamo da decenni e cioe' che i
Vaccini
producono nei soggetti sottoposti a
quelle infauste pratiche in-sanitarie, spacciate per
tecniche preventive,
Malnutrizione con perdita di fattori
vitali essenziali alla vita sana, alterazione e
perdita di:
flora batterica autoctona,
vitamine,
minerali,
proteine vitali), oltre alle
mutazioni genetiche occulte,
immunodepressioni,
intossicazioni,
infiammazioni
e
contaminazioni da
virus e/o batteri
pericolosi che nel tempo possono
produrre malattie
le piu' disparate ! - vedi:
Contenuto dei vaccini
vedi
Statistiche Istat
sui vaccini
Pag.
6 -
Pag. 7
-
Pag. 8
- Pag.
9 -
Pag. 10
-
Pag 11 -
Pag. 12
-
Pag. 13 -
Pag 14
- Pag 15
-
Pag. 16 -
Pag. 17
-
Pag. 18 -
Pag.19
-
Pag. 20 -
Pag. 21
vedi anche
Dati ISTAT sui
Vaccini
|
